Barclays PLC Intra Cellular Therapies, Inc. Put Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$14.35 - $26.64 $419,020 - $777,888
-29,200 Reduced 88.75%
3,700 $95,000
Q2 2019

Aug 14, 2019
BUY
$10.65 - $14.29 $281,160 - $377,256
26,400 Added 406.15%
32,900 $427,000
Q4 2018

Feb 14, 2019
BUY
$10.36 - $20.96 $46,620 - $94,320
4,500 Added 225.0%
6,500 $74,000
Q4 2017

Feb 14, 2018
BUY
$14.27 - $16.79 $28,540 - $33,580
2,000
2,000 $29,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.86B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email